Exploring the mechanism of cordycepin combined with doxorubicin in treating glioblastoma based on network pharmacology and biological verification

BACKGROUND: Glioblastoma is the most common and fatal primary malignant tumor in the central nervous system, and the prognosis is poor. Currently, there are no effective treatments for glioblastoma. Cordycepin is a natural active substance with significant anticancer activity and doxorubicin is a br...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing, Zhuang, Yuan-Dong, Zhang, Qiang, Liu, Shuang, Zhuang, Bing-Bo, Wang, Chun-Hua, Liang, Ri-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855715/
https://www.ncbi.nlm.nih.gov/pubmed/35186504
http://dx.doi.org/10.7717/peerj.12942

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855715/
https://www.ncbi.nlm.nih.gov/pubmed/35186504
http://dx.doi.org/10.7717/peerj.12942

Ejemplares similares